Narrow search
Showing 1 - 10 of 18,186
Cover Image
What is the value of explicit priority setting for health interventions? : a simulation study
Barlow, Euan; Morton, Alec; Saudamini Dabak; Engels, Sven; … - In: Health care management science : a new journal serving … 25 (2022) 3, pp. 460-483
Persistent link: https://www.econbiz.de/10013431754
Cover Image
Economic evaluation of healthcare interventions : old and new directions
Gray, Alastair M.; Wilkinson, Thomas - In: Oxford review of economic policy 32 (2016) 1, pp. 102-121
Persistent link: https://www.econbiz.de/10011579462
Cover Image
Chapter Seven. Theoretical Issues Relevant to the Economic Evaluation of Health Technologies
Meltzer, David O.; Smith, Peter C. - In: Handbook of health economics : volume 2, (pp. 433-469). 2011
Medical cost-effectiveness analysis (CEA) is perhaps the most widely applied tool to guide policy decisions concerning the use of health care resources. This chapter first reviews the rationale for and common practice of medical cost-effectiveness analysis. It seeks to place CEA within a...
Persistent link: https://www.econbiz.de/10014025581
Cover Image
An approach to quantify parameter uncertainty in early assessment of novel health technologies
Iskandar, Rowan; Federici, Carlo; Berns, Cassandra; … - In: Health economics 31 (2022), pp. 116-134
Persistent link: https://www.econbiz.de/10013433346
Cover Image
Methods for the economic evaluation of health care programmes
Drummond, Michael F. (contributor) - 2005 - 3. ed.
Persistent link: https://www.econbiz.de/10002980548
Cover Image
Economic evaluation in healthcare
Mallarkey, Gordon (contributor) - 1999
Persistent link: https://www.econbiz.de/10001402415
Cover Image
Evidence synthesis and targeting further research for adherence and stratification in health economic evaluations
Simons, Claire Louise - 2018
Persistent link: https://www.econbiz.de/10012386967
Cover Image
Methods for the economic evaluation of health care programmes
Drummond, Michael F. - 1997 - 2. ed.
Persistent link: https://www.econbiz.de/10013477028
Cover Image
Cost-effectiveness analysis of EGFR mutation testing in patients with non-small cell lung cancer (NSCLC) with gefitinib or carboplatin-paclitaxel
Arrieta, Oscar; Anaya Longaric, Pablo Andrés; … - In: The European journal of health economics : HEPAC ; … 17 (2016) 7, pp. 855-863
Persistent link: https://www.econbiz.de/10011654791